Business Wire

Alpha Cognition Announces $6.8 Million Private Placement

VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel ...
Business Wire

Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners

Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and ...
Morningstar

Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners

Link to Register: https://us06web.zoom.us/webinar/register/WN_5W_rY9BrSZ2eqv3dp_FqoQ About Alpha Cognition Inc. Alpha Cognition Inc. is a commercial stage ...
Seeking Alpha

Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury

VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies for debilitating ...
Yahoo Finance

Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution

VANCOUVER, British Columbia & GRAPEVINE, Texas, January 07, 2026--(BUSINESS WIRE)--Alpha Cognition, Inc. (the "Company", "we", "us" and "ours") (NASDAQ: ACOG), a ...
Yahoo Finance

Alpha Cognition to Present Clinical Data at ASCP Annual Meeting

VANCOUVER, British Columbia & DALLAS, October 06, 2025--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG), a commercial-stage biopharmaceutical company developing therapies for neurodegenerative ...
The Globe and Mail

Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury

Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders, today announced ...
Investing

Alpha Cognition raises $35 million in oversubscribed public offering

VANCOUVER & DALLAS - Alpha Cognition Inc. (NASDAQ:ACOG) has priced an oversubscribed public offering of 5.6 million common shares at $6.25 per share, raising approximately $35 million in gross ...